Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine whether an investigational medication called ketamine
is able to improve treatment outcomes for tobacco use disorder when delivered in conjunction
with brief motivational enhancement therapy. Participants will receive ketamine assisted
motivational enhancement therapy weekly for three weeks and there will be 2 follow up visits.
All visits will also consist of questionnaires and saliva samples will be taken. The overall
participation will last approximately 8 weeks.